Comparison Of Preoperative Ultrasound Guided Fascia Iliaca Block Versus Femoral Nerve Block for Proximal Femur Fractures Before Positioning for Spinal Anaesthesia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Chak Ninety-five North Branch, Punjab Province, Pakistan, 51600
- Sughra Shafi Medical Complex
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ASA I&II status patients coming for proximal femur fracture surgery
Exclusion Criteria:
- Patients with history of neurological disease (Alzheimer, dementia),
- Patients with known contraindication to regional anaesthesia (e.g., signs of infection at site of block, coagulation abnormality i.e. INR >1.55, platelet count <80,000)
- Patients with ASA III and IV status and patients with Known allergy to the study drug were excluded from study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group A Participants who received Ultrasound Guided Femoral Nerve Block
Participants in group-A were 42 which were assigned randomly and Femoral Nerve Block was done before spinal anaesthesia.
|
FNB was carried out as follows: the linear probe was kept in a "in line plane" approach to identify the femoral artery under ultrasound guidance.
The triangular, hyperechoic femoral nerve was identified as being situated lateral to the femoral artery.
The femoral artery was positioned next to an insulated 22 G needle.
Once the needle tip was located and a negative blood aspiration was obtained, a little amount of local anesthetic (injection bupivacaine 0.25%) was administered.
The remaining drug volume was injected based on weight (0.5 ml/kg) once the local anesthetic distribution was observed
|
|
Active Comparator: Group B Participants who received Ultrasound Guided Fascia Iliaca Block
Participants in group- B were 42 which were assigned randomly and Fascia Iliaca Block was done before spinal anaesthesia.
|
The FICB was administered as described.
We found the psoas muscle lateral to the femoral nerve.
The iliacus fascia, which extends deep into the fascia Lata, covers it.
Consequently, a double pop was felt after inserting the needle until it was between the psoas muscle and the fascia iliaca.
As with the previously described method, 1 mL of the local aesthetic solution was injected, and following a negative blood aspiration, the medication disseminated beneath the fascia iliaca.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Control
Time Frame: 05 minutes
|
In patients with proximal femur fractures pain assessment was done baseline before blocks and at five minutes after blocks administration.
Pain control assessment was done based on Visual Analogue Scale from 0-10.
|
05 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 12 (Israel lung Association)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.